Research Article

Identification of the Key Genes and Pathways in Esophageal Carcinoma

Table 3

GO annotation of upregulated DEGs in EC.

GO IDGO termCount-valueFDR

Biological process
GO:0007049Cell cycle1524.10E − 137.59E − 10
GO:0022402Cell cycle process1183.44E − 126.36E − 09
GO:0022403Cell cycle phase902.00E − 103.71E − 07
GO:0000278Mitotic cell cycle825.34E − 109.87E − 07
GO:0051301Cell division678.80E − 091.63E − 05
GO:0000279M phase706.27E − 081.16E − 04
GO:0000087M phase of mitotic cell cycle493.38E − 060.0062547
GO:0000280Nuclear division484.65E − 060.0086014
GO:0007067Mitosis484.65E − 060.0086014
GO:0048285Organelle fission496.41E − 060.011854
GO:0033554Cellular response to stress952.02E − 050.0373322
Cellular component
GO:0031974Membrane-enclosed lumen2761.12E − 101.65E − 07
GO:0043233Organelle lumen2702.41E − 103.56E − 07
GO:0043232Intracellular non-membrane-bounded organelle3598.74E − 101.29E − 06
GO:0043228Non-membrane-bounded organelle3598.74E − 101.29E − 06
GO:0070013Intracellular organelle lumen2594.54E − 096.71E − 06
GO:0031981Nuclear lumen2161.90E − 082.80E − 05
GO:0000775Chromosome, centromeric region362.52E − 083.72E − 05
GO:0005829Cytosol1921.36E − 060.0020016
GO:0015630Microtubule cytoskeleton924.62E − 060.0068255
GO:0000793Condensed chromosome326.75E − 060.009972
GO:0000779Condensed chromosome, centromeric region217.55E − 060.011151
GO:0044427Chromosomal part699.92E − 060.0146408
GO:0005635Nuclear envelope431.37E − 050.0202598
GO:0000777Condensed chromosome kinetochore191.48E − 050.0219025
GO:0005694Chromosome781.75E − 050.02589
GO:0000776Kinetochore222.72E − 050.0401619
Molecular function
GO:0000166Nucleotide binding3055.53E − 060.0090275
GO:0017076Purine nucleotide binding2665.55E − 060.0090714
GO:0030554Adenyl nucleotide binding2231.07E − 050.0175078
GO:0001883Purine nucleoside binding2251.49E − 050.0242774
GO:0032555Purine ribonucleotide binding2522.35E − 050.0383944
GO:0032553Ribonucleotide binding2522.35E − 050.0383944
GO:0001882Nucleoside binding2252.44E − 050.0398342

EC: esophageal carcinoma; FDR: false discovery rate.